ON THE PODIUM


PharmaVoice

August 2017

Awardee

"Red Jacket - 100 most Influential people in healthcare"


PharmaVoice

March 2017

Contributor

"Patient Stories"


PharmaVoice-Upfront

January 2017
“Wendy White Named Chair of Global Genes”

MMM Article

September 2016

“Alexion Uses Superheros social media to raise rare disease awareness”
http://www.mmm-online.com/campaigns/alexion-uses-superheros-social-media-to-raise-rare-disease-awareness/article/523651/

PharmaVoice

August 2016, PharmaVoice 100 Special Publication

Contributor
“Overcoming the Challenges that Hinder Innovation”
.


First Word

July 2016
Contributor
“Orphan Drug Commercial Models: Sustaining the Rare
Disease Business”
http://www.insightpharmareports.com/Affiliated-Reports/FirstWord/Orphan-Drug-Commercial-Models/


Patient Summit

Septemer 2017 

MC

Global Genes

Irvine CA


Patient Engagement -- Challenges and Opportunities

May 2017
Keynote
University of Rochester Technology and Rare Neurological Diseases Symposium
Rochester, NY
                                                     

Best Practices for Partnering with Disease Foundations and Patient Groups  

May 2017
Panelist
Cell and Gene Exchange
Washington DC


The Unique Challenges and Opportunities of Rare Disease Drug Development

March 2017
BIO-Europe Spring
Panelist

Barcelona, Spain

Support for Patients as Partners Through the Drug Development Lifecycle 

February 2017
Guest Speaker
2017 Rare Disease Day at National Institute of Health

Bethesda, MD

Wendy White Consulting

ASSESS

Wendy White is a thought leader working in rare diseases at the intersection of business, advocacy and technology. She was a pioneer in recognizing the power of patients and caregivers in influencing their own and their loved one’s outcomes and formulating innovative strategies for all stakeholders to work together for a common cause.  Wendy is bringing her expertise learned in working with over 36 rare communities on behalf of manufacturers, her experience on the board of both the National Organization of Rare Disorders (NORD) and Global Genes and an outstanding network in rare pharma to a consulting offering for pharmaceutical companies, bio-tech, service organizations and venture companies. With 20 years in rare disease, Wendy brings one of the industry's strongest track records to a slate of services that help clients efficiently and effectively identify the most compelling patient-engagement opportunities, as well as potential gaps that can impact commercialization plans for orphan drug launches.

Identifies gaps and opportunities in the rare disease community from clinical trials through commercialization for orphan drugs.

Evolve

IN THE NEWS

PLAN

twitter link

Develops and Monitors Key Performance Indicators (KPIs) at regular intervals, adjusting strategies and tactics as needed.

IMPLEMENT

Uses her network, expertise, and experience to audit/augment commercial plans.

Oversees the implementation process from start to finish.

Linkedin